ANTI-SOMATOSTATIN RECEPTOR (SST1), HUMAN
|
|
- $485 - $717
- Product name: ANTI-SOMATOSTATIN RECEPTOR (SST1), HUMAN
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:MFCD02097418
- Synonyms:ANTI-SSTR1;ANTI-SOMATOSTATIN RECEPTOR TYPE 1;ANTI-SOMATOSTATIN RECEPTOR (SST1), HUMAN;Anti-Somatostatin Receptor Type 1 antibody produced in rabbit;Anti-SSTR1, N-Terminal antibody produced in rabbit;SRIF-2;SS1R;SSTR1
4 prices
Selected condition：
Brand
- Biorbyt Ltd
- Sigma-Aldrich
- Usbiological
Package
- 10μg
- 100μG
- 100ul
- 50μl
- ManufacturerBiorbyt Ltd
- Product numberorb529964
- Product descriptionSSTR1
- Packaging10μg
- Price$707.2
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS1445
- Product descriptionAnti-Somatostatin Receptor Type 1 antibody produced in rabbit affinity isolated antibody, buffered aqueous solution
- Packaging50μl
- Price$717
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSAB4502862
- Product descriptionAnti-SSTR1, N-Terminal antibody produced in rabbit affinity isolated antibody
- Packaging100μG
- Price$485
- Updated2023-01-07
- Buy
- ManufacturerUsbiological
- Product number492897
- Product descriptionSSTR1
- Packaging100ul
- Price$499
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Biorbyt Ltd | orb529964 | SSTR1 | 10μg | $707.2 | 2021-12-16 | Buy |
| Sigma-Aldrich | S1445 | Anti-Somatostatin Receptor Type 1 antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 50μl | $717 | 2024-03-01 | Buy |
| Sigma-Aldrich | SAB4502862 | Anti-SSTR1, N-Terminal antibody produced in rabbit affinity isolated antibody | 100μG | $485 | 2023-01-07 | Buy |
| Usbiological | 492897 | SSTR1 | 100ul | $499 | 2021-12-16 | Buy |
Properties
storage temp. :−20°C
form :buffered aqueous solution
form :buffered aqueous solution
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|